Topical Immunotherapy of Alopecia Areata: A Large Retrospective Study
Authors:
Open Access
- 13 February 2018
- journal article
- research article
- Published by Springer Nature in Dermatology and Therapy
- Vol. 8 (1) , 101-110
Abstract
Topical immunotherapy is frequently used in the treatment of alopecia areata (AA) although few studies report long-term follow-up. Our goals were to determine the efficacy and the prognostic factors of topical immunotherapy in a large cohort of patients with AA treated in the departments of Dermatology and Venereology of Bergamo, Como and Pavia, from 1978 to January 2016.Keywords
This publication has 27 references indexed in Scilit:
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?Journal of Dermatological Science, 2017
- Comorbidity profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based studyJournal of the American Academy of Dermatology, 2011
- Alopecia areata updateJournal of the American Academy of Dermatology, 2010
- Alopecia areata updateJournal of the American Academy of Dermatology, 2010
- Alopecia areata: pathogenesis and potential for therapyExpert Reviews in Molecular Medicine, 2006
- A ?hairy? privilegeTrends in Immunology, 2005
- Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblastsMutation Research/Genetic Toxicology, 1996
- Prevalence of Alopecia Areata in the First National Health and Nutrition Examination SurveyArchives of Dermatology, 1992
- Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenoneJournal of the American Academy of Dermatology, 1991
- SYNCHRONOUS ALOPECIA AREATA IN TWO SIBLINGS: A POSSIBLE VIRAL ÆTIOLOGYThe Lancet, 1979